History of cgmp s & FDA. Richard Lombardi, Training Specialist Forest Laboratories, Inc.

Similar documents
Introduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES

EU and FDA GMP Regulations: Overview and Comparison

Clinical Trials and the Food and Drug Administration

Regulatory Schema for Blood Transfusion Microbiotal transplant conference

Clinical Trials and the Code of Federal Regulations. Darlene Kitterman, MBA Director, Investigator Support & Integration Services September 24, 2014

CGMP Requirements for Investigational Products

Food Safety Modernization Act (FSMA) & Imports of Food Products. August 9 th, 2016 Russell Statman, Registrar Corp

Drug Development & the FDA Pharmacy 309 November 2005

Chapter 29 Consumer Protection Name. Federal Communications Commission Federal Trade Commission FERPA Flammability Food and Drug Administration

Holly Rapp, MT(ASCP)SBB, CQA(ASQ)CQM/OE AABB

Regula'on of Contracep'ves

FDA FSMA Timeline. July 29, 2009 House version passed. Nov. 30, 2010 Senate version passed. Dec. 19, 2010 Senate revised version passed

Food and Drug Administration

Medical Device Labeling HealthPack 2004 Program

FDA Update on Compounding

GMP GUIDELINES. GMP Guides from Industry Organisations. FDA cgmp WHO GMP. cgmp Guide Drugs 21 CFR 210 GAMP. ISPE Technical Guides

US FDA: CMC Issues for INDs

Compliance Trends Paula Katz

FDA s Food Safety Modernization Act: An Overview

Theodore Sullivan Partner Quarles & Brady LLP (Washington, DC)

Overview of FDA Regulations and Guidance Documents related to PET Drug Chemistry. Steve Zigler, Ph.D. Siemens PETNET Solutions

Ethical Issues in Clinical Trial & Development of Regulation Policy on Clinical Research

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals

FDA Inspections. Purpose of an Inspection. FD&C Act Section 704(a): Factory Inspections 1. Authority to Inspect

Annual Industry Report

Important Contacts: Reporting the Recall

Important Contacts: Reporting the Recall

Overview. A brief from

DEPARTMENT OF HEALTH 81 HUMAN SERVICES

Guidance for Industry Compounding Animal Drugs from Bulk Drug Substances

WARNING LETTER. Below is the indication and summary of the most serious and most common risks associated with the use of Ampyra. 1

Disclosures. Laboratory Stakeholders. IVD vs. LDT. FDA Regulation of Laboratory Developed Tests 10/2/2015. FDA Regulation of LDTs

Inspection Trends. American Society for Quality Richmond, VA Section March 8, 2016

Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act

ROLE OF THE RESEARCH COORDINATOR Investigational New Drug Application-Sponsor Responsibilities 21CFR Part , subpart D

THANKSGIVING DINNER MATH PROJECT

Food and Drug Administration (FDA) 101

Appendix 3: Another look at the US IND annual report

Are you in or out? Overview of new regulations and who they apply to Faith Critzer Food Safety Assistant Professor

Food Fight: FSMA and the FDA s New Era of Enforcement. July By Sandra J. Wunderlich

Molecular Diagnostics: The Shift to Complexity. Molecular Diagnostics Regulation: Where do we go from here? David W Feigal, Jr.

Inspections, Compliance, Enforcement, and Criminal Investigations

January 24, WARNING LETTER (08-ATL-04 )

The FDA/CDRH Perspective in the Regulation of Surgical Mesh

GMPs: Distribution Centers

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.

Navigating an FDA GMP and Validation Inspection- Best Practices and Pitfalls

The Politics of Food & Agriculture

Structure and Mandate of FDA

A Guide to Food Safety Systems for Wineries as Required by FSMA

Statement of David G. Strunce President and Chief Executive Officer Scientific Protein Laboratories LLC

Harmonizing FDA Regulation and the Practice of Pharmacy: Challenges and Opportunities. Plus an update on PET Drug User Fees

Pharmacies and Outsourcing Services

White Paper: Food Safety Enforcement and Inspection Actions and Terminology

GUIDELINES FOR REGISTRATION OF MEDICINES IN THE GAMBIA

April 12, 2010 WARNING LETTER (10-ATL-12)

How do you know the drug you are using is safe and effective?

GMP SERIES - Chapter 2. Bridgewater, NJ. Paul A. Melamud Validation Manager QPharma, Inc.

Examine & Evaluate: Health Canada and FDA

Pharmaceutical Compounding Sterile and Nonsterile Preparations. Jeanne Sun, PharmD

(MPY-201 DRA) - ADVANCE DRA I

March 4, Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852

Pharmaceutical Reference Standards: Overview and Role in Global Harmonization

Testimony of Molly Ventrelli Vice President, Regulatory Affairs Fresenius Kabi USA, LLC

FDA Regulation of Food from GE Crops

Conducted Under an IND to Support a

Functional Classification of Medicine

Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.

2015 > Soft Computer Consultants, Inc. 4/30/15

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

Industry Perspective on PET Manufacturing Comparison of EU and US

Inspections, Compliance, Enforcement, and Criminal Investigations

GMP Requirements. Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP)

Arco Globus Trading LLC 12/11/17

Office for Human Subject Protection. University of Rochester

ACC February 2015 Quick Hit. FDA Hot Topics. David L. Rosen, B.S. Pharm., J.D. Foley & Lardner LLP (202)

January 22, WARNING LETTER CHI-03-09

Distinguishing Medical Device Recalls from Product Enhancements and Associated Reporting Requirements

FDA Draft Guidance for Industry Contract Manufacturing Arrangements for Drugs: Quality Agreements (May 2013) Pfizer Comments General Comments:

! Fundamental Aspect of Human Logic & Instinct" ! Risk? Probability of Damage" ! Risk Expression: Qualitative v. Quantitative?"

NYS Department of Agriculture and Markets Division of Food Safety and Inspection Field Operations Manual

Inspections, Compliance, Enforcement, and Criminal Investigations

FDA s Same Surgical Procedure Draft Guidance Could Stifle Use of Autologous Stem Cell Therapies

CGMP for Phase 1 INDs

July 3, WARNING LETTER CHI-3-08

Inspections, Compliance, Enforcement, and Criminal Investigations

Defining Clinical Benefit in Clinical Trials: FDA Perspective

Effectively Addressing and Remediating FDA's Form 483 Findings, Warning Letters and Consent Decree Compliance Issues

A.1 Contents file 4 to 5 A.1 (1)

Responding to an FDA 483

Drug Safety and FDA Revitalization Legislation

FSMA: Past, Present, Future

Supply Chain Supplier Quality Management. Nicholas Violand, Investigator/Drug Specialist US FDA, New Jersey District

Investigator-Initiated Research

*Brevity is the Soul of Wit.

Jeff Yuen and Associates, Inc. PO Box 6026 Orange, CA Zenaida Power Regulatory Expertise:

Implementation of the FSMA. Produce Safety Rule in VA

Information and resources for African Americans living with multiple myeloma and their caregivers

CDER 2016 Actions and 2017 Priorities. Richard Moscicki Deputy Center Director for Science Operations, CDER, FDA

FREQUENTLY ASKED QUESTIONS

Transcription:

History of cgmp s & FDA Richard Lombardi, Training Specialist Forest Laboratories, Inc. ASQ June 1, 2005

Not a second thought

What Ails Ya? Latham's Cathartic Extract: : Sick, headache, Impurities in the blood? Constipation? Here's your cure! Peruvian Syrup: : Cures Dropsy, Dyspepsia, Debility and Humors. Quite the comprehensive medicine! Electro-Voltaic Belt: : to men afflicted with nervous debility, loss of vitality and all kindred troubles. Also for Rheumatism, neuralgia, paralysis, and many other diseases. Munyon s Paw-Paw Pills: : They coax the liver into activity, they invigorate instead of weaken, & they enrich the blood instead of impoverishing it. (Corrects constipation.)

1883 -Dr. Wiley comes to Washington Food / Drug rules regulated by states Adulteration & misbranding increased by late 1800 s Wiley expanded research in this area Concerned over chemical preservatives in food

I believe in trying it on the dog - Harvey W. Wiley Christmas Dinner The Poison Squad dining room Apple Sauce Borax Soup Chipped Beef with Creamed Gravy or Turkey Borax Choice of Sweet or White Potato Canned String Beans Borax Cranberry Sauce, Pickles, Celery Rice Pudding Milk, Coffee or Tea A Little More Borax

1906 Publication of The Jungle by Upton Sinclair.

Get a Bill Passed NOW!!

1906 Pure Food and Drug Act Forbade commerce of adulterated / misbranded food & drugs Seized & condemned offending products Offending persons could be fined & jailed Accurate label statements Alcohol / Narcotic presence must be stated on the label

1937 - Sulfanilamide 7 to 21 days of symptoms stoppage of urine, severe abdominal pain, nausea, vomiting, stupor, and convulsions. intense pain. No known antidote or treatment for diethylene glycol poisoning.

1937 - Sulfanilamide 108 deaths Company was charged with misbranding.

1938 Food, Drug and Cosmetic Act New drug application (NDA) required showing drug safety. Safe tolerances set for unavoidable poisonous substances Directions for use and warnings about possible misuse also required unless the drug was sold by prescription Authorized factory inspections

Thalidomide O O N N O O

Kefauver-Harris Amendments Drug manufacturers must provide information on a drug s effectiveness as well as its safety Mandated record keeping 60-day review period eradicated Permitted FDA to withdraw approval Teratogenic testing required Clinical trial patient consent Dr. Kelsey receiving the Distinguished Federal Civilian Service Award from President John F. Kennedy Aug 7, 1962

Milestones 1962 - cgmp s Established in CFR for Drug Manufacture. 1978 - Major revisions to the cgmp s dealing with personnel & facilities, as well as products and processes. 1995 Proposed updates to cgmp s - stalled 1997 FDA Modernization Act globalized industry requires consistent and efficient regulatory requirements

cgmp s Write procedures and work instructions Follow procedures and instructions Document your work Validate / Qualify processes and equipment Design proper facilities & equipment Maintain and cleanse facilities, equipment & self Define, develop & demonstrate job competence Protect against contamination Control components & product related processes Conduct planned & periodic audits

Quality Systems Approach Six System Inspection Approach Quality System Facilities & Equipment Systems Production System Materials System Packaging & Labeling System Laboratory Controls System

2004 Risk-Based Approach High Risk Products & Processes Sterile drugs, aseptic filtration, prescription drugs High Risk Facilities New facilities, First application, Warning letter recipients, Sterile product manufacturers, Recalls Encourage technological Advances Train FDA on regulating technological advancement

Can we learn from this lesson, or can mankind educate itself only by disaster and tragedy? - Sen. Paul Douglas, on the acceptance of the Senate s 1962 drug bill

Sources www.fda.gov http://www.kevincmurphy.com/harveywiley.htm http://www.annals.org http://leda.law.harvard.edu

Thank You!